– USA, MI – Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), the leading developer of spider silk based fibers, today announced the appointment of Greg Scheessele, as the third and final independent Board member.
Over the last two weeks, the Company announced the selections of three new independent directors scheduled to join the Company’s board during the fourth quarter, including Anurag Gupta, Ms. Julie Bishop, and Greg Scheessele. The Company anticipates selecting one additional inside director to round out its board.
“We are pleased to welcome Greg to the Kraig Lab’s board in the role of an independent director,” said chairman and CEO, Kim Thompson. “Greg’s background, experience, and leadership-focused in businesses with global operations in manufacturing, industrial and life sciences sectors will be a tremendous asset to our corporate strategy as we continue on our growth trajectory. With this announcement, the Company has reached a new and important milestone in its corporate governance, advancing our business model.”
The addition of Mr. Scheessele to the board will expand the overall skill set, perspective and experience necessary to support and drive growth for all of the Company’s stakeholders. Mr. Scheessele has a strong history of leading successful business operations on a global scale.
Mr. Scheessele’s term will begin during the fourth quarter and he will serve on the audit and compensation committees for the duration of his time as a director.
Once these three new independent directors are formally seated, during the fourth quarter, the Company will be governed by a majority of independent directors, which is a key requirement for listing on a national exchange.
About Greg Scheessele
Mr. Scheessele currently serves as the CEO of Gerette, LLC and has held several top executive roles in global manufacturing firms including Executive Vice President, TMD Americas at TMD Friction Holdings GmbH; Group Vice President, Global Operations at Pall Corporation and Gelman Sciences; and Manufacturing Manager at General Motors Powertrain Division.
“I am very excited to join the Kraig Biocraft Laboratories board,” said Mr. Scheessele. “I look forward to supporting Kim Thompson and his team with their exciting work focusing on the development and commercialization of spider silk.”
Mr. Scheessele has served on various corporate and non-profit boards over the past twelve years.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc., a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
For more information: https://www.kraiglabs.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
